Trial 4P-18-2


SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Chemotherapy: Systemic, Hormone, Surgery
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Monish Aron, M.D.
Other Trial Staff:  Cheryl Kefauver, Coordinator, Vicky Araujo, Coordinator, Lagrimas Ilagan, D.M., Honorina Enright, D.M., Amanda Luna, D.M., Ileana Aldana, Coordinator, Hilma Bolton, Coordinator, Charis Barg, Coordinator, Jennifer Donaldson, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.